RE: Well, how was it for you?17 Dec 2025 10:56
To be honest BV it was exactly as expected, the results continue to show 90% disease control rate, extending the progression free survival and showing very little toxicity, in a cancer that currently has no standard of care....in other words the drug continues to save the lives of patients who previously held no hope.
Unfortunately, as is usual people were expecting miracles and partnership news, which was never the intent or likely outcome of this call. As a result I got an opportunity to purchase some more shares, which is all good with me, I'm in no rush.